Insiders · IMNN

IMNN insider transactions

Imunon Inc. (IMNN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IMNN

• 12d
  Executive Chairman of Board Tardugno Michael H was granted 4,089 shares, increasing direct ownership by 47% to 12,838 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 12d
  President and CEO Lindborg Stacy was granted 1,593 shares, increasing direct ownership by 44% to 5,235 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  Executive Chairman of Board Tardugno Michael H was granted 3,484 shares, increasing direct ownership by 66% to 8,749 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  Director Pellizzari Christine A was granted 5,557 shares, increasing direct ownership by 215% to 8,142 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  Director Dentzer James E was granted 11,148 shares, increasing direct ownership by 292% to 14,963 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  Director Braun Donald P was granted 5,011 shares, increasing direct ownership by 116% to 9,319 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  Director Fritz Frederick J. was granted 10,330 shares, increasing direct ownership by 274% to 14,097 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 25d
  President and CEO Lindborg Stacy was granted 1,491 shares, increasing direct ownership by 69% to 3,642 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 152d
  New insider Church Jeffrey Wayne claimed ownership of 26 shares (SEC Form 3)

  3 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by CFO Bragg Kimberly

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Chief Medical Officer Faller Douglas Vincent

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Director Dentzer James E

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 166d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 285d
  President and CEO Lindborg Stacy converted options into 1,667 shares, increasing direct ownership by 87% to 3,584 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  Director Dentzer James E was granted 3,318 shares (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  Director Pellizzari Christine A was granted 2,248 shares (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  Director Braun Donald P was granted 2,040 shares, increasing direct ownership by 120% to 3,747 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  Director Fritz Frederick J. was granted 3,161 shares, increasing direct ownership by 403% to 3,946 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  SEC Form 4 filed by CFO Bragg Kimberly

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 319d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 369d
  New insider Bragg Kimberly claimed ownership of 20,400 shares (SEC Form 3)

  3 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Director Dentzer James E

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Imunon, Inc. (0000749647) (Issuer)
• 460d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 487d
  SEC Form 4 filed by Chief Medical Officer Faller Douglas Vincent

  4 - Imunon, Inc. (0000749647) (Issuer)
• 488d
  SEC Form 3 filed by new insider Faller Douglas Vincent

  3 - Imunon, Inc. (0000749647) (Issuer)
• 509d
  Director Braun Donald P bought $29,480 worth of shares (25,000 units at $1.18), increasing direct ownership by 4,188% to 25,597 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 549d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 598d
  Amendment: SEC Form 4 filed by President and CEO Lindborg Stacy

  4/A - Imunon, Inc. (0000749647) (Issuer)
• 621d
  SEC Form 4 filed by General Counsel and Corp Sec Eylward Susan

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Director Dentzer James E

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 649d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 674d
  President and CEO Lindborg Stacy bought $24,500 worth of Imunon Common Stock (25,000 units at $0.98), increasing direct ownership by 10% to 264,166 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 674d
  Executive Chairman of Board Tardugno Michael H bought $25,750 worth of Imunon Common Stock (25,000 units at $1.03), increasing direct ownership by 8% to 353,346 units (SEC Form 4)

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Executive Chairman of Board Tardugno Michael H

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by President and CEO Lindborg Stacy

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Chief Scientific Officer Anwer Khursheed

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Director Fritz Frederick J.

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Director Pellizzari Christine A

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Director Dentzer James E

  4 - Imunon, Inc. (0000749647) (Issuer)
• 737d
  SEC Form 4 filed by Director Braun Donald P

  4 - Imunon, Inc. (0000749647) (Issuer)